BriaCell Therapeutics (BCTX) Short Interest Ratio & Short Volume → 1970’s computer coder Issues Shocking AI Warning (From InvestorPlace) (Ad) Free BCTX Stock Alerts $2.38 +0.14 (+6.25%) (As of 01:08 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media BriaCell Therapeutics Short Interest DataCurrent Short Volume685,000 sharesPrevious Short Volume677,900 sharesChange Vs. Previous Month+1.05%Dollar Volume Sold Short$1.59 millionShort Interest Ratio / Days to Cover8.1Last Record DateApril 15, 2024Outstanding Shares15,980,000 sharesFloat Size14,040,000 sharesShort Percent of Float4.88%Today's Trading Volume40,030 sharesAverage Trading Volume81,979 sharesToday's Volume Vs. Average49% Short Selling BriaCell Therapeutics ? Sign up to receive the latest short interest report for BriaCell Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBCTX Short Interest Over TimeBCTX Days to Cover Over TimeBCTX Percentage of Float Shorted Over Time Ad Huge AlertsThis 1 Biotech Stock has been shocking the marketsSave the Date: BioStem's 2024 Q1 Call Coming Up!Sign Up for the Live Broadcast here BriaCell Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024685,000 shares $1.59 million +1.1%4.9%8.1 $2.32 3/31/2024677,900 shares $1.94 million -7.6%4.8%7.2 $2.86 3/15/2024733,300 shares $2.16 million -7.9%5.2%6.8 $2.95 2/29/2024795,900 shares $2.75 million -2.8%5.7%7.7 $3.46 2/15/2024818,800 shares $2.64 million -6.1%5.8%8.3 $3.23 1/31/2024871,900 shares $3.59 million +1.0%6.2%9.2 $4.12 Get the Latest News and Ratings for BCTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024863,700 shares $3.79 million +0.6%6.2%7.6 $4.39 12/31/2023858,500 shares $5.02 million +1.6%6.1%8 $5.85 12/15/2023845,200 shares $3.49 million -11.2%6.0%8.8 $4.13 11/30/2023951,900 shares $5.04 million -2.8%6.8%10.5 $5.29 11/15/2023979,100 shares $4.31 million +3.8%7.0%10 $4.40 10/31/2023943,400 shares $4.01 million -7.5%7.1%9.2 $4.25 10/15/20231,020,000 shares $5.00 million -2.9%7.7%12 $4.90 9/30/20231,050,000 shares $6.56 million -3.7%8.0%12.5 $6.25 9/15/20231,090,000 shares $6.63 million -3.5%8.3%11.8 $6.08 8/31/20231,130,000 shares $8.12 million +3.7%8.6%11.9 $7.19 8/15/20231,090,000 shares $7.54 million +3.8%8.3%11.8 $6.92 7/31/20231,050,000 shares $7.02 million +1.0%8.0%10 $6.69 7/15/20231,040,000 shares $6.71 million -1.0%9.1%9.4 $6.45 6/30/20231,050,000 shares $6.74 million -4.6%9.2%8.4 $6.42 6/15/20231,100,000 shares $6.67 million -12.7%9.7%8.8 $6.06 5/31/20231,260,000 shares $7.47 million -6.0%11.4%9.9 $5.93 5/15/20231,340,000 shares $8.80 million -3.6%12.2%9.6 $6.57 4/30/20231,390,000 shares $10.34 million -4.1%12.6%9.1 $7.44 4/15/20231,450,000 shares $10.44 million +1.4%13.2%8.6 $7.20 3/31/20231,430,000 shares $10.65 million -4.7%13.9%7.6 $7.45 3/15/20231,500,000 shares $10.50 million -6.3%14.6%7.1 $7.00 2/28/20231,600,000 shares $11.33 million +4.6%15.5%7.2 $7.08 2/15/20231,530,000 shares $12.22 million +1.3%14.9%6.7 $7.99 1/31/20231,510,000 shares $11.29 million +15.3%14.7%6.7 $7.48 1/15/20231,310,000 shares $8.71 million -0.8%12.6%5.1 $6.65 12/30/20221,320,000 shares $5.77 million -5.7%12.7%5.6 $4.37 12/15/20221,400,000 shares $7.87 million No Change13.5%5.6 $5.62 11/30/20221,400,000 shares $7.52 million No Change13.5%4.1 $5.37 11/15/20221,400,000 shares $7.69 million +12.9%13.5%3.8 $5.49 10/31/20221,240,000 shares $6.82 million -10.1%11.9%3.2 $5.50 10/15/20221,380,000 shares $9.12 million +3.8%13.3%3.4 $6.61 9/30/20221,330,000 shares $7.47 million -16.9%12.8%3.4 $5.62 9/15/20221,600,000 shares $12.91 million +2.6%15.4%3.9 $8.07 8/31/20221,560,000 shares $12.12 million +4.0%15.0%4.2 $7.77Obama’s Forever Term [exposed] (Ad)America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.Start streaming it now at no cost here BCTX Short Interest - Frequently Asked Questions What is BriaCell Therapeutics' current short interest? Short interest is the volume of BriaCell Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 685,000 shares of BCTX short. 4.88% of BriaCell Therapeutics' shares are currently sold short. Learn More on BriaCell Therapeutics' current short interest. What is a good short interest ratio for BriaCell Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BCTX shares currently have a short interest ratio of 8.0. Learn More on BriaCell Therapeutics's short interest ratio. Which institutional investors are shorting BriaCell Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BriaCell Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for BriaCell Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.88% of BriaCell Therapeutics' floating shares are currently sold short. Is BriaCell Therapeutics' short interest increasing or decreasing? BriaCell Therapeutics saw a increase in short interest in April. As of April 15th, there was short interest totaling 685,000 shares, an increase of 1.0% from the previous total of 677,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is BriaCell Therapeutics' float size? BriaCell Therapeutics currently has issued a total of 15,980,000 shares. Some of BriaCell Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BriaCell Therapeutics currently has a public float of 14,040,000 shares. How does BriaCell Therapeutics' short interest compare to its competitors? 4.88% of BriaCell Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to BriaCell Therapeutics: CASI Pharmaceuticals, Inc. (0.99%), Fortress Biotech, Inc. (13.02%), Marker Therapeutics, Inc. (1.00%), Apollomics, Inc. (0.32%), ProMIS Neurosciences, Inc. (0.16%), ImmunoPrecise Antibodies Ltd. (1.58%), Spruce Biosciences, Inc. (0.74%), JanOne Inc. (1.72%), DURECT Co. (3.19%), Viracta Therapeutics, Inc. (2.50%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short BriaCell Therapeutics stock? Short selling BCTX is an investing strategy that aims to generate trading profit from BriaCell Therapeutics as its price is falling. BCTX shares are trading up $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BriaCell Therapeutics? A short squeeze for BriaCell Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BCTX, which in turn drives the price of the stock up even further. How often is BriaCell Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCTX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: CASI Pharmaceuticals Short Interest Fortress Biotech Short Interest Marker Therapeutics Short Interest Apollomics Short Interest ProMIS Neurosciences Short Interest ImmunoPrecise Antibodies Short Interest Spruce Biosciences Short Interest JanOne Short Interest DURECT Short Interest Viracta Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BCTX) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe Exchange348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmith